5 RECOMBINANT DNA PRODUCTS FOR USE IN THE TREATMENT OF GENETIC DISORDERS NAMELY NUCLEIC ACID VACCINES, GENE THERAPY VECTORS, FUSION PROTEIN VACCINES, CANCER VACCINES, AND INFECTIOUS DISEASE VACCINES EXCLUDING PHARMACEUTICALS USED IN THE TREATMENT OR PREVENTION OF HEPATITIS A, B, C, D, E, or F